|
EFCAB7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63014046705712E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73440184226115E-11 |
| Normal-vs-Stage2 |
3.24079996172344E-09 |
| Normal-vs-Stage3 |
6.8441918799067E-12 |
| Normal-vs-Stage4 |
3.18767234830375E-12 |
| Stage1-vs-Stage2 |
1.559550E-01 |
| Stage1-vs-Stage3 |
2.661700E-02 |
| Stage1-vs-Stage4 |
1.921250E-03 |
| Stage2-vs-Stage3 |
8.104800E-01 |
| Stage2-vs-Stage4 |
3.000800E-01 |
| Stage3-vs-Stage4 |
3.769200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.59392548843607E-14 |
| Normal-vs-AfricanAmerican |
2.14419999999826E-05 |
| Normal-vs-Asian |
1.16019999996109E-06 |
| Caucasian-vs-AfricanAmerican |
9.855200E-01 |
| Caucasian-vs-Asian |
4.036800E-01 |
| AfricanAmerican-vs-Asian |
5.753200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.99504906723314E-12 |
| Normal-vs-Female |
1.70252700826268E-12 |
| Male-vs-Female |
9.115800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.72220024299941E-10 |
| Normal-vs-Age(41-60Yrs) |
7.38342720296714E-12 |
| Normal-vs-Age(61-80Yrs) |
2.78888023785839E-12 |
| Normal-vs-Age(81-100Yrs) |
8.49820000000667E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.961390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.759900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.197190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.216600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.993800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.949000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.837500E-03 |
| Classical-VS-Follicular |
2.801200E-01 |
| Classical-VS-Other |
4.457000E-01 |
| Classical-VS-Normal |
2.79259999569348E-08 |
| Tall-VS-Follicular |
6.072200E-02 |
| Tall-VS-Other |
1.735150E-01 |
| Tall-VS-Normal |
1.26459953619928E-10 |
| Follicular-VS-Other |
3.548800E-01 |
| Follicular-VS-Normal |
1.26239999564959E-08 |
| Other-VS-Normal |
9.268300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.07425221232916E-12 |
| Normal-vs-N1 |
1.7901999882497E-09 |
| N0-vs-N1 |
5.040000E-01 |
|
|
